Evidence map›Paper›PMID 26010717›Full record

ReviewGlia2015

NG2-glia and their functions in the central nervous system.

L Dimou, V Gallo

Abstract readReview
In one paragraph

Review in Glia, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 156 papers.

0numbers the graph read from it
0cells of the map it votes in
156citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

156 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Frontiers in cell and developmental biology · 2026
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Pericytes in the optic nerve head.Progress in retinal and eye research · 2025
    Review

96 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

L DimouPhysiological Genomics, Biomedical Center, Ludwig-Maximilians University, Munich, 80336, Germany.
V GalloCenter for Neuroscience Research, Children's Research Institute, Children's National Medical Center, Washington, District of Columbia.

Funding

NEUROIMAGING COREP30HD040677 · NICHD · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2001 to 2015
$15.9M
ROLES OF HIF-1a IN THE VASCULATURE DURING RECOVERY FOLLOWING CHRONIC SUBLETHAL HYP01NS062686 · NINDS · YALE UNIVERSITY · PI SCHWARTZ, MICHAEL L · 2009 to 2013
$6.6M
A Common Glial-Neuronal Progenitor in Postnatal BrainR01NS045702 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2004 to 2014
$3.7M
Role of Endothelin-1 in remyelinationR01NS090383 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2014 to 2018
$1.9M
Characterization of Sox17 as a Regulator of Oligodendrocyte Cell DifferentiationR01NS056427 · NINDS · CHILDREN'S RESEARCH INSTITUTE · PI VITTORIO GALLO, VITTORIO GALLO VITTORIO GALLO · 2007 to 2011
$1.8M
NICHD NIH HHS P30 HD040677NICHD NIH HHS P30HD40677NINDS NIH HHS P01 NS062686NINDS NIH HHS P01NS062686NINDS NIH HHS R01 NS045702NINDS NIH HHS R01NS045702NINDS NIH HHS R01 NS056427NINDS NIH HHS R01NS056427NINDS NIH HHS R01 NS090383
6 · The paper itself

Abstract

In the central nervous system, NG2-glia represent a neural cell population that is distinct from neurons, astrocytes, and oligodendrocytes. While in the past the main role ascribed to these cells was that of progenitors for oligodendrocytes, in the last years it has become more obvious that they have further functions in the brain. Here, we will discuss some of the most current and highly debated issues regarding NG2-glia: Do these cells represent a heterogeneous population? Can they give rise to different progenies, and does this change under pathological conditions? How do they respond to injury or pathology? What is the role of neurotransmitter signaling between neurons and NG2-glia? We will first give an overview on the developmental origin of NG2-glia, and then discuss whether their distinct properties in different brain regions are the result of environmental influences, or due to intrinsic differences. We will then review and discuss their in vitro differentiation potential and in vivo lineage under physiological and pathological conditions, together with their electrophysiological properties in distinct brain regions and at different developmental stages. Finally, we will focus on their potential to be used as therapeutic targets in demyelinating and neurodegenerative diseases. Therefore, this review article will highlight the importance of NG2-glia not only in the healthy, but also in the diseased brain.

Indexed as

AnimalsCentral Nervous SystemHumansNeurogliadiseaseheterogeneitylineage potentialoligodendrocyte progenitorsphysiology

Identifiers

PMID26010717
PMCPMC4470768

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.